Biomedical subjects
Jeffrey P Koplan
Publications and source records attributed to Jeffrey P Koplan.
Shingles vaccine: effective and costly or cost-effective?
Explore the source record for details and available documents.
Improving the world's health through national public health institutes.
Explore the source record for details and available documents.
Preventing childhood obesity: health in the balance: executive summary.
Explore the source record for details and available documents.
The algebra of condoms and abstinence.
Explore the source record for details and available documents.
Saving lives through global safe water.
Explore the source record for details and available documents.
Public health: which road will it take?
Explore the source record for details and available documents.
Hormone therapy: making decisions in the face of uncertainty.
Explore the source record for details and available documents.
Practical methods for public health practitioners.
Explore the source record for details and available documents.
America's emergency care system and severe acute respiratory syndrome: are we ready?
Explore the source record for details and available documents.
The Master Settlement Agreement--further evaluation required.
Explore the source record for details and available documents.
Plagues, public health, and politics.
Explore the source record for details and available documents.
Communication during public health emergencies.
Explore the source record for details and available documents.
Are health disparities on the public health agenda? Where?
Explore the source record for details and available documents.
Bioterrorism preparedness and response: clinicians and public health agencies as essential partners.
Explore the source record for details and available documents.
Women and smoking: a report of the Surgeon General.
Explore the source record for details and available documents.
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.
The small world of global health.
This article is based on the Solomon Berson lecture, delivered by Dr. Koplan in January 2000. In his remarks, Dr. Koplan discussed the current status of global health and projected trends in three categories: communicable diseases, risk factors for disease, and selected diseases and health conditions. Reflecting on differences in health issues in the 30 years since he left Mount Sinai, Dr. Koplan pointed out that the health problems of developed and developing nations are strikingly similar now which also means they are amenable to similar interventions.